Lotus Healthcare Inc.
|
Lotus Healthcare Inc.
|
|
|
Lotus Healthcare Inc. is a privately held pharmaceutical Company which was
established in 1994 to specialize in supplying the rapidly growing use of
narcotic medicines for pain management in the Chinese Market. The Company is
invested by a group of pharmaceutical executives with extensive experience of
operational company management both in China and internationally. Weihai Lotus
is the Group’s wholly owned subsidiary located in the coastal Province of
Shandong, one hours flying time east of Beijing. There, Lotus Healthcare has
constructed a modern solid dosage form manufacturing facility which is GMP
Approved by the Chinese Authorities. Weihai Lotus is one of a very few select
companies which is authorized by the China Government for operations with
narcotic medicines. The Company conducts product development, manufactures,
promotes
Thank
you for visiting, you are most welcome to browse and additional information may
be obtained by downloading our
|
|
Your Healthcare Partner in China |
and distributes a range of narcotic based medicines. Galake®, a
dihydrocodeine and paracetamol combination tablet is currently in the market as
is Lutilium® a gastrokinetic, these will shortly be joined by SRM-Rhotard, a
sustained release morphine sulphate product which has just been approved for
bioavailability studies prior to marketing by Weihai Lotus. Other products in the development pipeline include
oxycodone, naloxone and naltrexone.